• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 9, Issue 4
  3. Author

Online ISSN: 2515-8260

Volume9, Issue4

Uric acid levels in patients on antitubercular therapy at Dr. B.R. Ambedkar Medical College, Bengaluru

    Dr. Srinivasa KV, Dr. Priya VR, Dr. Shantha Kumari N, Dr. Karthik G

European Journal of Molecular & Clinical Medicine, 2022, Volume 9, Issue 4, Pages 354-357

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

Background: Tuberculosis is an infectious disease caused by mycobacterium tuberculosis. The disease burden is huge in developing country like India. Antitubercular therapy is the mainstay of treatment. The drugs in the therapy can cause various adverse effects. Hyperuricemia is one of the adverse effects caused. Aim: To estimate the levels of serum uric acid level in patients taking antitubercular therapy including pyrazinamide. Materials and Methods: A prospective study done at DR. BR AMC and H including the 60 patients on antitubercular therapy. Serum uric acid levels are estimated at 0 and 8 weeks of therapy. Results: Hyperuricemia was significant in patients receiving antitubercular therapy with pyrazinamide. Serum urate level 6.7 +/- 0.6 mg/dl compared to baseline 4.3+/- 0.8 mg/dl. Hyperuricemia was seen in 46.6%. Conclusion: Patients on antitubercular therapy including pyrazinamide developed significant hyperuricemia.
Keywords:
  • PDF (342 K)
  • XML
(2022). Uric acid levels in patients on antitubercular therapy at Dr. B.R. Ambedkar Medical College, Bengaluru. European Journal of Molecular & Clinical Medicine, 9(4), 354-357.
Dr. Srinivasa KV, Dr. Priya VR, Dr. Shantha Kumari N, Dr. Karthik G. "Uric acid levels in patients on antitubercular therapy at Dr. B.R. Ambedkar Medical College, Bengaluru". European Journal of Molecular & Clinical Medicine, 9, 4, 2022, 354-357.
(2022). 'Uric acid levels in patients on antitubercular therapy at Dr. B.R. Ambedkar Medical College, Bengaluru', European Journal of Molecular & Clinical Medicine, 9(4), pp. 354-357.
Uric acid levels in patients on antitubercular therapy at Dr. B.R. Ambedkar Medical College, Bengaluru. European Journal of Molecular & Clinical Medicine, 2022; 9(4): 354-357.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 70
  • PDF Download: 99
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus